Company

At AHB, we are committed to creating a healthy and sustainable future for humanity by pioneering disruptive synthetic biology technologies and innovations.

View more
Sustainability

We're committed to sustainability with our Triple Zero goals (0 CO₂ emissions, 0 waste, 0 fossil energy) and are advancing zero-carbon tech, circular economy, and renewable energy to drive a sustainable future.

View more
News & Events

Welcome to AHB, we share the most cutting-edge information in the industry with you in real time, inviting you to enter the era of synthetic biology.

View more
Careers

Today's AHB, our global team brings together professionals from various disciplines around the world, all united for a common goal: to create a sustainable future for mankind. So, are you ready to join us?

View more

AHB won another ESG award as listed in the 2023 Forbes China ESG Innovation Enterprise

November 02, 2023

Share

Recently, the 2023 Forbes China ESG Innovation Enterprise list was announced, covering various industries such as industrial manufacturing, finance, and environmental protection. AHB, with its continuous efforts and outstanding performance in the ESG field, has proudly made it to the list. Other notable companies included in the list are JD.com, Haier, CATL, Siemens, and other industry leaders.

The 2023 Forbes China ESG Innovation Enterprise Selection aims to showcase the differentiation advantages of Chinese enterprises in the ESG innovation field by collecting representative innovative samples across industries such as industrial growth, ESG practice, innovation execution, and industry influence. In this year’s selection, 50 companies that have achieved positive results in the ESG field stood out, providing valuable examples for ESG practices among Chinese enterprises.

In recent years, while maintaining sustained growth in performance, AHB has actively explored various aspects of ESG in environmental protection, social welfare, and corporate governance.

In the field of environmental protection, AHB focuses on green technology innovation and the creation of green value, integrating the concept of low-carbon and energy-saving throughout the entire product lifecycle to drive the green development of the entire industry chain. In the realm of social responsibility, AHB actively engages in various public welfare and charity activities, collaborating with employees, customers, suppliers, and partners to jointly achieve dual-carbon goals. In the area of corporate governance, AHB possesses a mature and effective corporate governance structure, safeguarding investor interests through a comprehensive information disclosure system and rich investor communication platforms, thus contributing to the company’s long-term development.

Looking ahead, AHB plans to further integrate ESG principles with corporate culture and management, driven by technological innovation and advanced manufacturing capabilities. This will promote the integration of technology and industry in the synthetic biology field, continuously shape new green growth drivers, and build a high-quality development engine.